T's Pharma
Privately held: no public share price · Japan
Assets
(2 total)
2Total Assets
0Approved
1Phase 3 / Filed
1Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
VogliboseNo recent activity | Phase 3 | Alpha-glucosidaseSmall molecule | Type 2 Diabetes |
| Preclinical / Unstaged | Angiotensin II type 1 receptor / L-type calcium channelSmall molecule | Hypertension |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.